Cytocast is an emerging TechBio startup based in Budapest, specializing in data-driven medical technology. The company offers the CYTOCAST DIGITAL TWIN Platform™, an
innovative platform that predicts drug candidate side effects by simulating billions of molecular interactions within human cells. This technology aims to revolutionize drug
discovery by accelerating processes, reducing costs, and increasing clinical trial success rates. Additionally, Cytocast is developing the CYTOCAST DIGITAL TWIN
Population™ and the CYTOCAST DIGITAL TWIN Personalized™. Such technologies will facilitate data-driven, personalized healthcare by tailoring treatments based on
unique patient molecular characteristics. Their approach leverages multi-omics and single-cell data to better understand cellular health impacts from diseases and drugs.